trending Market Intelligence /marketintelligence/en/news-insights/trending/Mu7A3HPi_HDtsX74VPniIQ2 content esgSubNav
In This List

Daxor chief medical officer dies

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Daxor chief medical officer dies

Daxor Corp. founder and Chief Medical Officer Joseph Feldschuh died Jan. 31.

Feldschuh, who was working on a part-time basis, was the first president and CEO of the company. He was undergoing treatment for pancreatic cancer and unexpectedly developed sepsis during the last two days.

Michael Feldschuh will continue in the president and CEO role.

The transition process for the chief medical officer role was ongoing at the time of Joseph Feldschuh's death, but the company does not expect significant functional difficulties arising from the transition process and is confident in the necessary expertise and resources to meet all foreseeable future needs.